tipFebruary 16, 2021 36
The global esoteric testing market is expected to reach US$ 45,081.6 Mn in 2025 from US$ 19,868.2 in 2017. The market is estimated to grow with a CAGR of 11.7% from 2018-2025.
Request for sample PDF Copy @
Esoteric testing market is segmented by technology, test type, and end user. Global esoteric testing market, based on technology was segmented into chemiluminescence immunoassay, real-time PCR, flow cytometry, mass spectrometry, enzyme-linked immunosorbent assay and others. Global esoteric testing market, based on the test type was segmented into infectious diseases testing, oncology testing, genetic testing, neurology testing, endocrinology testing, toxicology testing and others. The end users segment for the esoteric testing market is classified as hospital laboratories, and independent & reference laboratories.
Quest Diagnostics To Speak At Citi s 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference
News provided by
Share this article
Share this article
SECAUCUS, N.J., Feb. 16, 2021 /PRNewswire/ Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced that it is scheduled to speak at Citi s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference. Mark Guinan, Executive Vice President & CFO will discuss the company s vision, goals, and capital deployment strategies. The presentation is scheduled for Wednesday, February 24, 2021 at 1:30 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available on the company s investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 48 hours after the conclusion of the live event and will remain available until March 26, 2021.
Data Bridge Market Research recently added “
Global Non- Invasive Prenatal Testing Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Global Non- Invasive Prenatal Testing Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Non-invasive prenatal testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 11.26 billion by 2027 growing at a CAGR of 15.57% in the above-mentioned forecast period. Rising healthcare expenditure worldwide is expected to create new opportunity for the marke
Share:
New York, Feb. 15, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Women s Health Diagnostics Market by Application, End User, COVID-19 Impact – Global Forecast to 2025 - https://www.reportlinker.com/p04407705/?utm source=GNW The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market s growth to a certain extent.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global pharmacogenomics market will reach $12.83 billion by 2030, growing by 8.1% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of pharmacogenomics for drug discovery and development amid COVID-19 pandemic.
Highlighted with 88 tables and 83 figures, this 181-page report Global Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS), Application, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global pharmacogenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019